| Item Type | Name |
|
Academic Article
|
National study of U.S. emergency department visits with diabetic ketoacidosis, 1993-2003.
|
|
Academic Article
|
Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993-2005.
|
|
Academic Article
|
Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department.
|
|
Academic Article
|
Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.
|
|
Academic Article
|
National study of the emergency physician workforce, 2008.
|
|
Academic Article
|
Multicenter study of knowledge about human papilloma virus and attitudes among emergency department patients.
|
|
Academic Article
|
Body mass index and acute asthma severity among children presenting to the emergency department.
|
|
Academic Article
|
Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
|
|
Academic Article
|
Use of midlevel providers in US EDs, 1993 to 2005: implications for the workforce.
|
|
Academic Article
|
Update on midlevel provider utilization in U.S. emergency departments, 2006 to 2009.
|
|
Academic Article
|
Vitamin D, respiratory infections, and asthma.
|
|
Academic Article
|
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey.
|
|
Academic Article
|
Supply and demand of board-certified emergency physicians by U.S. state, 2005.
|
|
Academic Article
|
Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D?
|
|
Academic Article
|
Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005.
|
|
Academic Article
|
Limited communication and management of emergency department hyperglycemia in hospitalized patients.
|
|
Academic Article
|
Fatal toxic shock syndrome from an intrauterine device.
|
|
Academic Article
|
Characteristics of U.S. emergency departments that offer routine human immunodeficiency virus screening.
|
|
Academic Article
|
PAs and malpractice.
|
|
Concept
|
Ghana
|
|
Concept
|
Trauma Centers
|
|
Concept
|
Violence
|
|
Concept
|
Intrauterine Devices
|
|
Concept
|
Data Interpretation, Statistical
|
|
Concept
|
Specialty Boards
|
|
Concept
|
Educational Status
|
|
Concept
|
Calcitriol
|
|
Concept
|
Brain Injuries
|
|
Concept
|
Calcifediol
|
|
Concept
|
Certification
|
|
Concept
|
Decision Support Systems, Clinical
|
|
Concept
|
Emergency Service, Hospital
|
|
Concept
|
Device Removal
|
|
Concept
|
Acetaminophen
|
|
Concept
|
Cholecalciferol
|
|
Concept
|
Domestic Violence
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Critical Care
|
|
Academic Article
|
Randomized controlled trial of calcitriol in severe sepsis.
|
|
Academic Article
|
Reply: active and native vitamin D in critical illness.
|
|
Grant
|
Colorado PETAL Clinical Center
|
|
Concept
|
Conservative Treatment
|
|
Concept
|
Brain Injuries, Traumatic
|
|
Academic Article
|
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
|
|
Academic Article
|
Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.
|
|
Academic Article
|
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.
|
|
Academic Article
|
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
|
|
Academic Article
|
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults =18 Years in 11 Outpatient Health Care Facilities - United States, July 2020.
|
|
Academic Article
|
Telework Before Illness Onset Among Symptomatic Adults Aged =18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020.
|
|
Academic Article
|
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
|
|
Academic Article
|
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
|
|
Academic Article
|
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.
|
|
Academic Article
|
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
|
|
Academic Article
|
Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States.
|
|
Academic Article
|
Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.
|
|
Academic Article
|
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.
|
|
Academic Article
|
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.
|
|
Academic Article
|
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged =65 Years - United States, January-March 2021.
|
|
Academic Article
|
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
|
|
Academic Article
|
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
|
|
Academic Article
|
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
|
|
Academic Article
|
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
|
|
Academic Article
|
Corticosteroid Administration and Impaired Glycemic Control in Mechanically Ventilated COVID-19 Patients.
|
|
Academic Article
|
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
|
|
Academic Article
|
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
|
|
Academic Article
|
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
|
|
Academic Article
|
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
|
|
Academic Article
|
Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients.
|
|
Academic Article
|
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
|
|
Academic Article
|
Clinical impact of a prehospital trauma shock bundle of care in South Africa.
|
|
Academic Article
|
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
|
|
Academic Article
|
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
|
|
Academic Article
|
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
|
|
Academic Article
|
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
|
|
Academic Article
|
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
|
|
Academic Article
|
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
|
|
Academic Article
|
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
|
|
Academic Article
|
Trial of Early Antiviral Therapies during Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19: a summary of the protocol and analysis plan for a decentralized randomized controlled trial.
|
|
Academic Article
|
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia.
|
|
Academic Article
|
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
|
|
Academic Article
|
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
|
|
Academic Article
|
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
|
|
Academic Article
|
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
|
|
Academic Article
|
Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes.
|
|
Academic Article
|
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States.
|
|
Academic Article
|
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.
|
|
Academic Article
|
Clinician Perspectives on Monoclonal Antibody Treatment for High-Risk Outpatients with COVID-19: Implications for Implementation and Equitable Access.
|
|
Academic Article
|
Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness.
|
|
Academic Article
|
ED-based COVID-19 vaccination campaign finds higher vaccination rates for individuals from racial and ethnic minority groups compared with clinic setting.
|
|
Academic Article
|
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.
|
|
Academic Article
|
Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
|
|
Academic Article
|
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
|
|
Academic Article
|
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
|
|
Academic Article
|
"All of the things to everyone everywhere": A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19.
|
|
Academic Article
|
Effect of Ivermectin 600 µg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial.
|
|
Academic Article
|
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged =65 Years - IVY Network, 18 States, September 8-November 30, 2022.
|
|
Academic Article
|
Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial.
|
|
Academic Article
|
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
|
|
Academic Article
|
Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase.
|
|
Academic Article
|
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
|
|
Academic Article
|
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
|
|
Academic Article
|
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
|
|
Academic Article
|
Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: A qualitative study of clinician perspectives.
|
|
Academic Article
|
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial.
|
|
Academic Article
|
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
|
|
Academic Article
|
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
|
|
Academic Article
|
Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study.
|
|
Academic Article
|
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
|
|
Academic Article
|
A multimodal strategy to improve race/ethnic group equity in administration of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
|
|
Academic Article
|
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
|
|
Academic Article
|
Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5.
|
|
Academic Article
|
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
|
|
Academic Article
|
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
|
|
Academic Article
|
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
|
|
Academic Article
|
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
|
|
Academic Article
|
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
|
|
Academic Article
|
Tixagevimab/cilgavimab for preventing COVID-19 during the Omicron surge: retrospective analysis of National Veterans Health Administration electronic data.
|
|
Academic Article
|
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
|
|
Academic Article
|
Modifiable in-hospital factors for 12-month global cognition, post-traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID-19.
|
|
Academic Article
|
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged =60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.
|
|
Academic Article
|
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
|
|
Academic Article
|
Effectiveness of Sotrovimab in Preventing COVID-19-Related Hospitalizations or Deaths Among US Veterans During Omicron BA.1.
|
|
Academic Article
|
Real-world data to evaluate effects of a multi-level dissemination strategy on access, outcomes, and equity of monoclonal antibodies for COVID-19.
|
|
Academic Article
|
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial.
|
|
Academic Article
|
The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials.
|
|
Academic Article
|
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
|
|
Academic Article
|
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.
|
|
Academic Article
|
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022.
|
|
Academic Article
|
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged =18 Years - VISION and IVY Networks, September 2024-January 2025.
|
|
Academic Article
|
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
|
|
Academic Article
|
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.
|
|
Academic Article
|
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.
|
|
Academic Article
|
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
|
|
Academic Article
|
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.
|
|
Academic Article
|
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged =18 Years - VISION and IVY Networks, September 2023-January 2024.
|
|
Academic Article
|
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.
|
|
Academic Article
|
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study.
|
|
Academic Article
|
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism.
|
|
Academic Article
|
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.
|
|
Academic Article
|
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
|
|
Academic Article
|
Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID-19.
|
|
Academic Article
|
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024.
|
|
Academic Article
|
Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5.
|
|
Academic Article
|
Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
|
|
Academic Article
|
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial.
|
|
Academic Article
|
A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies.
|
|
Academic Article
|
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.
|
|
Academic Article
|
Rapid methods for multi-level dissemination of neutralizing monoclonal antibody treatment for COVID-19 outpatients: designing for dissemination using the fit to context framework.
|
|
Academic Article
|
Circulating Interleukin-6 Levels and Timing of Acute Ischemic Stroke Onset.
|
|
Academic Article
|
Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19.
|
|
Academic Article
|
Identification of HIF1A as a therapeutic target during SARS-CoV-2-associated lung injury.
|
|
Academic Article
|
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.
|
|
Academic Article
|
Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment.
|
|
Academic Article
|
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
|
|
Academic Article
|
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial.
|
|
Academic Article
|
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial.
|
|
Academic Article
|
External Validation of a Novel Lung Injury Prevention Score for the Emergency Department.
|
|
Academic Article
|
Association of remdesivir treatment with long-term mortality after COVID-19 hospitalization.
|
|
Academic Article
|
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19.
|
|
Academic Article
|
Dipeptidyl peptidase-3 to predict respiratory outcomes in patients hospitalized with COVID-19: A secondary analysis of a multicenter randomized trial.
|
|
Academic Article
|
Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022-September 2023.
|
|
Academic Article
|
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial.
|
|
Academic Article
|
Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission.
|